Search clinical trials for: Indacaterol maleate and glycopyrronium bromide
Total 1812 results
-
Novartis PharmaceuticalsCompletedCOPDGermany, Belgium, Poland, Romania, Italy, Spain, Estonia, Russian Federation, Austria, France, Slovakia, Czechia, Latvia, Lithuania, Greece, Hungary, United Kingdom, Portugal, Ireland, Norway, Slovenia, Denmark, Sweden
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingChronic Obstructive Pulmonary DiseaseChina
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease | COPDGermany
-
Orion Corporation, Orion PharmaCompletedHealthy VolunteersFinland
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Novartis PharmaceuticalsCompletedAsthmaGermany, United Kingdom
-
University of SaskatchewanCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Greece, Belgium, Bulgaria, Turkey, Hungary, Slovakia, Spain, United Kingdom, Russian Federation, Ireland
-
Novartis PharmaceuticalsRecruitingAsthmaSpain, Hungary, United Kingdom, South Africa, Colombia, Guatemala, Bulgaria, Poland
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Russian Federation, Taiwan, Canada, Germany, Philippines, South Africa, Spain, United Kingdom, Turkey, Hungary, Guatemala, Australia, Bulgaria, France, Poland, Switzerland, Slovakia, Japan
-
University of MilanFondazione Salvatore MaugeriCompleted
-
NovartisMerck Sharp & Dohme LLCCompleted
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States, Argentina, Germany, Russian Federation, France, Israel, Korea, Republic of, Italy, Poland, Chile, Mexico, Peru, Canada, Hungary, Netherlands, New Zealand
-
Orion Corporation, Orion PharmaCompleted
-
Novartis PharmaceuticalsCompletedAsthmaItaly, Germany, France
-
Novartis PharmaceuticalsCompleted
-
Dr. Grace ParragaNovartis PharmaceuticalsWithdrawn
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseCanada
-
Daewoong Pharmaceutical Co. LTD.Completed
-
NovartisCompleted
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
NovartisCompletedLung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive | COPDBelgium
-
Prosonix LimitedCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaMenarini GroupCompletedPulmonary Disease, Chronic ObstructiveItaly, Spain, United Kingdom, Germany, Hungary
-
AstraZenecaCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Argentina, Australia, Canada, Mexico, New Zealand, South Africa
-
Mundipharma Research LimitedTerminatedACOS (Fixed Airflow Obstruction and Elevated Eosinophils)Slovakia
-
Dr. August Wolff GmbH & Co. KG ArzneimittelCompletedPrimary Axillary HyperhidrosisGermany
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
AstraZenecaCompletedA Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)Andorra, Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
Botanix PharmaceuticalsCompletedPrimary Axillary HyperhidrosisUnited States
-
Celldex TherapeuticsCompletedBreast CancerUnited States
-
AstraZenecaCompleted
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
-
Cothera Bioscience, IncRecruitingLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphatic Diseases | Burkitt Lymphoma | High-grade B-cell Lymphoma | C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma | C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma | Lymphoma, High-Grade | C-Myc Gene RearrangementKorea, Republic of, China
-
Novartis PharmaceuticalsCompletedAsthmaGermany, United States, Belgium, Latvia, Lithuania, Japan
-
NPO PetrovaxCompletedInfections, CoronavirusBelarus, Russian Federation
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveChina, Korea, Republic of
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
University of MilanFondazione Salvatore MaugeriCompletedChronic Obstructive Pulmonary DiseaseItaly
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Spain, Turkey, France, Netherlands, Germany
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseRussian Federation, Singapore, United States, Canada, Korea, Republic of, Japan, Spain, Turkey, Romania, Australia, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany